Michał Babicz

Michał Babicz

Auto-generated profile, based on publicly available information

Michał Babicz

Jan Kochanowski University, Kielce, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
OMOliwer Műller
Oliwer Műller
MBMichał Babicz
Michał Babicz
KCKamil Chudzicki
Kamil Chudzicki
WCWiktor Czyżewski
Wiktor Czyżewski
DDDaria Danielczyk
Daria Danielczyk
PŻPaweł Żurek
Paweł Żurek
Artificial intelligence (AI) and machine learning (ML) are increasingly being proposed as tools to strengthen antimicrobial stewardship (AMS), particularly where antibiotic decisions depend on large volumes of clinical, microbiological, and prescribing data. This review synthesizes recent PubMed-indexed full-text evidence on AI in AMS, with emphasis on clinical application, predictive performance, implementation readiness, and governance. A structured narrative review was conducted using a targeted PubMed search updated on 8 March 2026. English-language peer-reviewed full-text papers published from 2017 through early 2026 were eligible when they addressed antimicrobial prescribing, susceptibility or resistance prediction, rapid diagnostic support, stewardship workflow, implementation, or ethical and organizational aspects of AI-enabled prescribing. Thirty-four papers were retained for structured synthesis, and two additional papers were used for contextual framing. The evidence indicates that AI is most mature in bounded stewardship tasks, especially individualized empiric prescribing, resistance prediction, rapid diagnostic interpretation, and prioritization of stewardship interventions. Newer open-access studies also show movement toward reusable stewardship datasets, real-time triage tools, and models for high-risk populations. However, the field remains dominated by retrospective, single-centre, and syndrome-specific studies, while external validation, workflow evaluation, and post-deployment governance are still limited. Current evidence therefore supports AI as a useful adjunct to stewardship teams rather than an autonomous replacement for clinical judgment.

30 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MBMichał Babicz
Michał Babicz
OMOliwer Muller
Oliwer Muller
KRKatarzyna Rosa
Katarzyna Rosa
ASAgata Słoma
Agata Słoma
JPJagoda Pałubska
Jagoda Pałubska
PŻPaweł Żurek
Paweł Żurek
Objective: To integrate recent evidence on the ways neighborhood social vulnerability and rural residence influence emergency presentation in colon cancer and the care trajectory that follows surgery. Methodology: This narrative review examined PubMed-indexed literature identified through a targeted search on March 5, 2026. Systematic reviews, multicenter observational studies, and intervention studies published in English between 2013 and 2026 were prioritized, with preference for colon-specific evidence and selective inclusion of colorectal studies when directly applicable to colon cancer pathways. Results: The literature points to a consistent pathway: socially vulnerable and rural populations are screened less often, enter care later, undergo non-elective surgery more frequently, and face greater difficulty completing postoperative and adjuvant care. Studies also suggest that provider availability, Commission on Cancer accreditation, patient navigation, and telehealth-supported follow-up can mitigate part of this disadvantage, although digital strategies remain constrained by broadband access, language barriers, and digital literacy. Conclusion: Emergency colon cancer surgery is best interpreted as a downstream marker of inequity across the care continuum. Efforts to reduce it should connect public-health outreach, access planning, perioperative care, and technology-enabled continuity rather than treating the emergency operation as an isolated event.

30 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
NMNatalia Malatyńska
Natalia Malatyńska
MBMichał Babicz
Michał Babicz
KCKamil Chudzicki
Kamil Chudzicki
WCWiktor Czyżewski
Wiktor Czyżewski
DDDaria Danielczyk
Daria Danielczyk
PŻPaweł Żurek
Paweł Żurek
Burnout in health care workers is usually monitored through intermittent self-report instruments, which makes early recognition of occupational distress difficult and often delays intervention. Wearables, smartwatches, and other forms of passive sensing offer a more continuous approach to tracking sleep, physiological stress, activity, and recovery patterns that may precede clinically relevant deterioration in well-being. This structured narrative review synthesizes current evidence on passive sensing and wearable technologies for burnout-related outcomes in health care workers, with particular attention to digital biomarkers, implementation barriers, organizational moderators, and ethical governance. The review corpus combines direct sensing studies in physicians, residents, and nurses with contextual literature on workplace interventions, resilience, documentation burden, digital phenotyping ethics, and workplace biosensors. Current direct evidence remains limited. Existing studies do not yet support a stable physiological biomarker of burnout itself. Stronger and more consistent signals appear for acute stress, depressive trajectories, resilience-related patterns, sleep disruption, and recovery. A randomized clinical trial suggests that smartwatch-supported self-monitoring may improve physician burnout and resilience, while feasibility research shows that adherence depends heavily on device fit, workflow compatibility, and perceived personal value. Overall, wearables appear more mature as tools for monitoring stress, sleep, and resilience than for directly predicting burnout. Their future value will depend on stronger reporting standards, integration of workplace-context data, and transparent, non-punitive governance that prioritizes trust.

30 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KCKamil Chudzicki
Kamil Chudzicki
MBMichał Babicz
Michał Babicz
OMOliwer Muller
Oliwer Muller
JPJagoda Pałubska
Jagoda Pałubska
KRKatarzyna Rosa
Katarzyna Rosa
PŻPaweł Żurek
Paweł Żurek
This review examines how non-invasive biomarker technologies are reshaping hepatocellular carcinoma (HCC) surveillance in cirrhosis when considered not only as diagnostic tools but also as socio-technical interventions. A structured narrative review was developed from a targeted full-text corpus covering biomarkers, precision surveillance, cost-effectiveness, surveillance harms, and disparities in access and outcomes. The literature was coded thematically across five domains: biomarker technologies, precision surveillance models, economic value, patient burden, and equity and implementation. The reviewed evidence shows that surveillance is moving from a one-size-fits-all ultrasound-based model toward hybrid, risk-stratified systems that combine blood-based biomarkers, algorithmic scores, and selective advanced imaging. Composite scores such as GALAD and HES V2.0 improve early-stage detection compared with single markers, while recent modeling studies suggest that biomarker-based or precision surveillance can be cost-effective under realistic assumptions about test performance, adherence, and price. However, adoption is constrained by assay standardization, reimbursement, false-positive workup, psychological and financial harms, and persistent disparities related to insurance, mental health, transportation, language, and digital access. The main conclusion is that the future of HCC screening is not simply a better biomarker but a better surveillance system. Research and policy should therefore evaluate analytic performance together with workflow fit, patient acceptability, equity, governance, and real-world implementation.

27 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
DDDaria Danielczyk
Daria Danielczyk
MBMichał Babicz
Michał Babicz
KCKamil Chudzicki
Kamil Chudzicki
WCWiktor Czyżewski
Wiktor Czyżewski
KRKatarzyna Rosa
Katarzyna Rosa
PŻPaweł Żurek
Paweł Żurek
Bee-derived products such as honey and propolis are increasingly used as foods, supplements, and components of traditional and complementary medicine. At the same time, public health systems face antibiotic overuse, a rising burden of chronic diseases, and an expanding market of natural products whose quality, safety, and claims are variable. This review synthesizes recent peer-reviewed evidence on honey- and propolis-based products with an emphasis on (i) clinically and socially relevant application areas, (ii) public health determinants of safe use (knowledge, regulation, and information pathways), and (iii) modern technologies that can improve standardization, authentication, and consumer protection. A targeted narrative review was conducted using PubMed, PMC, and Google Scholar, prioritizing recent reviews, clinical and preclinical studies, and analytical quality-control research. The literature suggests the strongest and most mature evidence base for symptom relief in selected pediatric respiratory infections, alongside emerging but heterogeneous findings in chronic disease contexts (e.g., metabolic and kidney-disease populations). Across indications, major translation barriers include variability in botanical origin and composition, inconsistent preparations and dosing, contamination and adulteration risks, and uneven professional guidance. Survey data indicate important knowledge gaps among healthcare professionals and highlight social media as a dominant information source, raising concerns about misinformation-driven use. Advances in chemical analytics (spectroscopy, chromatography-mass spectrometry), DNA-based botanical verification, and non-thermal decontamination approaches can strengthen quality assurance. Integrating these technologies with clearer governance and health-professional education may help translate honey and propolis into responsible, evidence-aligned public health practices.

25 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ASAnna Szot
Anna Szot
MBMichał Babicz
Michał Babicz
KCKamil Chudzicki
Kamil Chudzicki
WCWiktor Czyżewski
Wiktor Czyżewski
DDDaria Danielczyk
Daria Danielczyk
ASAgata Słoma
Agata Słoma
This narrative review synthesizes current evidence on physical activity and structured exercise in adults with metabolic dysfunction-associated steatotic liver disease (MASLD), with particular emphasis on aerobic exercise, resistance training, and high-intensity interval training (HIIT). The manuscript was prepared as a structured review of guideline documents, systematic reviews, meta-analyses, randomized controlled trials, and selected observational studies identified primarily through PubMed-based searching and full-text source analysis. Because the overlap between historical non-alcoholic fatty liver disease (NAFLD) and current MASLD populations is nearly complete, earlier NAFLD exercise studies were treated as directly relevant to present-day MASLD. The reviewed literature shows that exercise consistently reduces liver fat, improves cardiorespiratory fitness, enhances insulin sensitivity, and favorably modifies body composition and selected cardiovascular risk markers, often without clinically significant weight loss. Aerobic exercise remains the best-studied modality, but resistance training also appears effective and may be especially valuable in patients with low fitness or concern about muscle loss. HIIT seems feasible and potentially beneficial in selected patients when appropriately supervised. Evidence for direct histological or fibrosis-specific benefit is promising but less robust than the evidence for steatosis and cardiometabolic outcomes. Overall, the findings support physical activity as a central lifestyle intervention in MASLD and highlight the importance of individualized prescription, adherence support, and technology-assisted delivery in future practice.